SCHEMBL583307

SCHEMBL583307

O=C(OC(Cl)(Cl)CCl)OC(Cl)(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7735640 0.85 TSHR (0.31)
SCHEMBL8318077 0.85
SCHEMBL22228981 0.85
SCHEMBL236720 0.83
SCHEMBL9230924 0.82
SCHEMBL3022 0.80
SCHEMBL11203180 0.80
SCHEMBL969229 0.80
SCHEMBL10617622 0.79
SCHEMBL7439608 0.78 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981939-B2 Process for the preparation of 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl) oxy] benzonitrile (Crisaborole) BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2021-04-20 US claimed
US-20200062785-A1 NOVEL PROCESS FOR THE PREPARATION OF 4-[(1-HYDROXY-1,3-DIHYDRO-2,1-BENZOXABOROL-5-YL) OXY] BENZONITRILE (CRISABOROLE) BIOPHORE INDIA PHARMACEUTICALS PVT. LTD., (IN) 2020-02-27 US claimed
WO-2018207216-A1 NOVEL PROCESS FOR THE PREPARATION OF 4-[(1-HYDROXY-1,3-DIHYDRO-2,1-BENZOXABOROL-5-YL) OXY] BENZONITRILE (CRISABOROLE) BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2018-11-15 WO claimed
EP-0581980-B1 3- and/or 4-substituted derivatives of quinic acid and process to prepare 3- and/or 4-substituted derivatives of quinic acid NESTLE SA (CH) 1999-03-03 EP claimed
EP-0581979-B1 Quinic acid derivatives and process to prepare quinic acid derivatives NESTLE SA (CH) 1999-03-03 EP claimed
US-5446134-A Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1995-08-29 US claimed
US-5401858-A Preparation of quinic acid derivatives NESTEC S.A. (CH) 1995-03-28 US claimed
US-5395950-A Production of quinic acid derivatives NESTEC S.A. (CH) 1995-03-07 US claimed
EP-0581980-A1 3- and/or 4-substituted derivatives of quinic acid and process to prepare 3- and/or 4-substituted derivatives of quinic acid SOCIETE DES PRODUITS NESTLE S.A. (CH) 1994-02-09 EP claimed
EP-0581979-A1 Quinic acid derivatives and process to prepare quinic acid derivatives SOCIETE DES PRODUITS NESTLE S.A. (CH) 1994-02-09 EP claimed
US-20260034234-A1 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS AGENSYS, INC. (US) 2026-02-05 US disclosed
EP-4615439-A2 SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS Humanwell Pharmaceutical US, Inc. (US) 2025-09-17 EP disclosed
EP-2970112-B1 PHENYL CARBAMATE COMPOUND AND A COMPOSITION FOR PREVENTING OR TREATING A MEMORY LOSS-RELATED DISEASE COMPRISING THE SAME BIO PHARM SOLUTIONS CO LTD (KR) 2025-03-12 EP disclosed
EP-4423103-A1 DNA-ENCODED AND AFFINITY-TAGGED MASKED-WARHEAD COMPOUNDS AND USE THEREOF IN ASSEMBLING LIBRARIES OF SMALL MOLECULES ENABLED FOR LATE-STAGE PURIFICATION AND MULTIPLEXED SCREENING OF COVALENT LIGANDS Maianti, Juan Pablo (US) 2024-09-04 EP disclosed
US-20240174693-A1 SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) 2024-05-30 US disclosed
WO-1993018018-A1 PROCESS FOR THE PREPARATION OF TAXOL AND 10-DEACETYLTAXOL UNIVERSITY OF FLORIDA (US) 1993-09-16 WO disclosed
US-5200534-A Process for the preparation of taxol and 10-deacetyltaxol UNIVERSITY OF FLORIDA (US) 1993-04-06 US disclosed
US-4960881-A REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1990-10-02 US disclosed
US-4841043-A Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates BRISTOL-MYERS COMPANY (US) 1989-06-20 US disclosed
EP-0257419-A1 Process for the preparation of antibacterial 7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1988-03-02 EP disclosed